Don’t let gene patents make a comeback

The Coons-Tillis legislation did not advance in 2019, after opposition was voiced by a range of advocacy groups, Nobel Laureates, and private companies. However, a group of legislators, industry representatives and patent lawyers have again escalated the campaign to revive gene patenting. Recently, at the request of Senators Tillis, Coons and others, the Patent Office issued a request for public input on how current law has “impacted investment and innovation, particularly in critical technologies like … precision medicine, diagnostic methods, and pharmaceutical treatments.”

Read more here: Source link